Inception, Innovation, Revolution: Emergence of Medical Robotics and Computer-Assisted Surgery in Healthcare Industry

October 9, 2014

Information technology plays a key role in an ever-widening range of human activities, including surgery. Medical robotics and computer-assisted surgery (MRCAS) are used in a growing number of operating rooms around the world, largely as a result of the growing popularity of minimally invasive surgical (MIS) techniques. MIS utilizes special instruments that can be inserted and manipulated through small incisions (sometimes no more than a few millimeters long) under remote optical or video guidance, greatly reducing patient trauma and recovery times.

The global market for medical robotics and computer-assisted surgical equipment was worth nearly $2.7 billion in 2013. The market is projected to approach $3.3 billion in 2014 and $4.6 billion by 2019 for a compound annual growth rate (CAGR) of 7% between 2014 and 2019, reports BCC Research. The U.S. accounted for more than 71% of the global MRCAS market in 2013, a share that BCC Research expects to increase to 74.7% by 2019. Europe is the second-largest geographical market for MRCAS, with over 22% of the market in 2013, declining to 18.1% in 2019. The Asia-Pacific region is the fastest-growing market, with a 2014 through 2019 CAGR of 13.4%.

Next generation robot assisted surgical devices are perhaps one of the most advanced developments in the field of medical science. Increasing desire of both patients and surgeons for the most efficient and advanced treatment options is encouraging hospitals to adopt these surgical instruments not only to provide value to their patients and doctors but also to reinforce their reputations.

As the technology is largely being integrated into the medical field, the use and demand of robot-assisted surgical systems is increasing both in developing and developed economies. Presence of untapped growth opportunities in emerging countries such as India, Brazil, and China is expected to serve this market as potential growth opportunities in the future. The demand is basically driven by growing awareness about the potential benefits among patients, surgeons and hospitals, favorable demographic trends, increased expenditure on healthcare, and increasing prevalence of chronic diseases.

According to Xie Ming, founder of Smart Robot Technology Group, China has a chance to develop its own brands in medical robots, especially those used in surgery. Currently, the da Vinci surgical robot is grabbing all the media attention in China. A creation of Intuitive Surgical, Inc., USA; the robot completed its first operation at the provincial hospital in Chengdu in the southwestern province of Sichuan on Sept. 9, 2014. It successfully removed a patient’s gallbladder in approximately 30 minutes.

The growing demand for medical robotics in the healthcare industry has increased significantly over the last few years. People are witnessing a whole new phase of healthcare with automation of surgeries because of its unprecedented accuracy, precision and enhanced dexterity for surgeons, and faster recovery period coupled with reduced pain and discomfort for patients. Technological advancements such as expanded applications of robotic systems, robotics combined with imaging platforms, and capsule robot systems are expected to drive the growth of the global medical systems market in the coming years.

It is, however, important to note that the surgical robots do not replace humans but rather enhance their capabilities to operate with superior visualization of the surgical field, motion scaling, and improved control while filtering the tremor inherent in the human wrist. The worldwide market for robotic surgical technologies holds significant promise and is expected to gradually replace traditionally used methods of surgeries.

For our relevant BCC Research report on medical robotics, visit the following link:

http://www.bccresearch.com/market-research/healthcare/medical-robotics-mrcas-market-hlc036f.html


Parkinson’s Disease: Robin Williams’ Death In Retrospect

September 4, 2014

Parkinson’s disease and its symptoms are by no means new illnesses.  More than one million Americans live with Parkinson’s disease. This number is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy and amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). Approximately 60,000 Americans are diagnosed with Parkinson’s disease yearly. This number does not reflect the thousands of cases that go undetected. An estimated 7 million to 10 million people worldwide are living with Parkinson’s disease.

Parkinson’s disease is caused by the loss of dopamine-producing neurons. This loss results in symptoms that include body rigidity and tremors. Symptoms are initially less pronounced but become more prominent as the disease progresses. Patients at the later stages suffer from a multitude of symptoms, including difficulty in sleeping or performing simple tasks (walking, talking, chewing, etc.), skin problems, constipation and also often suffer from depression.

The disease gained much of its attention from famous people, most notably actor Michael J. Fox, boxer Muhammad Ali, and singer Johnny Cash.

While the shocking news of iconic comedian Robin Williams’ death is still fresh in the minds and hearts of the people, with memorials and acts of remembrance taking place across the U.S. and other parts of the world, it was Williams’ wife Susan Schneider who revealed the personal battle the world-class comedian was facing: Parkinson’s disease.

Williams’ death has also shed light on the link between Parkinson’s disease and depression. According to Dr. Prashant Gajwani, Associate Professor of Psychiatry at the University of Texas at Houston, “What people need to understand is that depression and Parkinson’s disease both affect the brain.”

Dr. Gajwani further added, “There’s certain neurochemicals that are involved in both the diseases that have shared common pathways such as serotonin and dopamine. So, what happens is people who get Parkinson’s disease are at a higher risk for getting depressed.”

Neurological diseases such as Parkinson’s are complex diseases and the use of biomarkers will help elucidate relevant mechanisms that cause the disease and are responsible for disease progression. In the case of Parkinson’s, scientists believe that there may be a number of biological factors responsible for the disease, including changes in the mitochondria, oxidative stress, excitotoxicity or trophic factors.

Parkinson’s disease has become focused on biomarkers both from the standpoint of diagnostic test development to that of surrogates to assess the effectiveness of drugs to monitoring the progression of the disease or positive response to treatment scheme. Research into this area had been funded by the NIA, NINDS and the Parkinson’s Foundation, and by private foundations such as the Michael J. Fox Foundation.

 

For our relevant reports on Parkinson’s disease, visit the following links:

 

   References:


Growing Awareness of Amyotrophic Lateral Sclerosis (ALS) Around the World

September 1, 2014

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. It is a rapidly progressive and fatal neurological disease characterized by the gradual degeneration and death of motor neurons.

According to BCC Research reports, between one and two cases per 100,000 population appear every year; the disease commonly strikes people between 40 and 60 years of age, and men are slightly more prone to it than women. It has been estimated that there are 30,000 to 40,000 cases of ALS in the U.S. at any one time, and at least 200,000 in the developed world. Clearly, the global prevalence is much higher. Read the rest of this entry »


U.S. market for elder care products and services to reach $436.6 billion by 2018

August 29, 2014

With more than 12% of the global population over 65 years old, communities increasingly face the challenge of providing appropriate healthcare, housing, and technologies to accommodate and enhance this segment’s daily life. An increasingly aging population, advancements in the delivery of healthcare services, improving nutrition, and rising cases of chronic diseases such as heart disease and cancer will drive steady growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the U.S. elder care products and services market through its report, The Elder Care Market: Products and Services. According to the report, this market was valued at $286.7 billion in 2012 and $319.8 billion in 2013. BCC Research projects the market to grow to $436.6 billion by 2018, and register a five-year compound annual growth rate of 6.4% from 2013 to 2018.

RSS Feeds – Healthcare

Use this report for, but not limited to, the following reasons:

  • Gain an in-depth analysis and forecast of the eldercare market
  • Analyze market trends, with data from 2012 and 2013, and projections of CAGRs for the period 2013 and 2018
  • Identify U.S. and worldwide markets by demographics
  • Assess international markets, as well as information on the industry’s structure
  • Breakdown the overall market into segments that include healthcare products and services, housing services and needs, and assistive technologies
  • Review comprehensive company profiles of major players in the industry
SAMPLE FIGURE
PROJECTED NEEDS OF THE ELDERLY BY TYPE OF NEED, 2013 AND 2018
(%)

1387877321_HLC062B-0

Click here to order your copy of this report (or any of its chapters) or to download the report overview.


Global market for sludge treatment and odor control equipment to reach $9.2 billion by 2019

August 28, 2014

Larger quantities of wastewater combined with more advanced levels of treatment are resulting in increased sludge volumes across the globe. Although most wastewater, and hence most sludge, is treated in municipal sewage plants, the industrial sector is also growing steadily. In developed countries, where basic sludge handling is already widely practiced, advanced technologies, such as those for energy recovery and biogas production, drive the market. The sludge handling industry is inherently conservative in adopting new technologies. However, increasingly strict regulations and a desire to beneficially reuse sludge are helping to expand the market and consequently, witness steady growth in the foreseeable future.

BCC Research provides a thorough analysis of the global wastewater treatment and odor control equipment market through its report, Municipal and Industrial Sludge Treatment and Odor Control: The Global Market. According to the report, this market was valued at nearly $6.5 billion in 2013. This is forecast to reach nearly $6.9 billion by 2014-end. At this rate, the market value will reach $9.2 billion by 2019 with a compound annual growth rate (CAGR) of 5.9% during the years 2014 to 2019.

RSS Feeds – Environment

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for industrial and municipal sludge treatment and odor control equipment and related technologies
  • Analyze global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019
  • Information on regulations affecting these markets, market trends, and competitive structures within these markets
  • Gain an insight into the current issues affecting the industry, equipment types, legislation relevant to the markets, and end user requirements affecting developments
  • Review profiles of companies that are active in various market sectors
SAMPLE FIGURE
GLOBAL MARKET SIZE AND GROWTH FOR SLUDGE TREATMENT AND ODOR CONTROL EQUIPMENT, BY SEGMENT, 2005–2019
($ MILLIONS)

1403856447_ENV010C-0

Click here to order your copy of this report (or any of its chapters) or to download the report overview.


Global market for DNA vaccines to reach $2.7 billion in 2019

August 25, 2014

The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis and immunobiology enable rational design approaches. These new technologies allow pharmaceutical firms to discover and develop high-value vaccines for novel applications, creating a substantial new market opportunity.

BCC Research provides a detailed report on the DNA vaccines in its report, DNA Vaccines: Technologies and Global Markets. According to this report, the global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to $305.3 million by 2014-end. This is further estimated to reach $2.7 billion by 2019, registering a CAGR of 54.8% from 2014 through 2019.

RSS Feeds – Biotechnology

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for DNA vaccines and related technologies
  • Analyze global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019
  • Access details concerning delivery and synthesis technologies, the forces driving market growth, product formats, and market applications for these products
  • Obtain information most useful for biotechnology, DNA plasmid, gene therapy, DNA delivery, pharmaceutical, vaccine, animal health, and biodefense companies
  • Review profiles of leading companies in the field as well as updates to alliance, merger, and acquisition activity
SAMPLE FIGURE
GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, 2013–2019
($ MILLIONS)1406027309_BIO067B-0

Click here to order your copy of this report (or any of its chapters) or to download the report overview.


Global market for sealants and sealant applicators to reach $24.1 billion by 2019

August 21, 2014

The sealant industry has been growing steadily across all sectors, including automotive, construction, electronics, transportation, and others. Demand is being driven by the emergence of new market applications resulting from improved assembly processes. Near-term growth in this market will be shaped by increasing miniaturization of electronic components and the development of nanoengineered sealants with superior wear resistance and dimensional stability.

BCC Research provides an in-depth analysis of the global markets for sealants and sealant applicators through its report Sealants and Sealant Applicators: Technologies and Global Markets. According to the report, this market reached nearly $19.1 billion in 2013 and is estimated to hit $19.8 billion in 2014. BCC Research projects the market to grow to $24.1 billion by 2019, and register a five-year compound annual growth rate (CAGR) of 4% from 2014 to 2019.

RSS Feeds – Chemicals

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global sealants and sealant applications market
  • Analyze global market trends, with data from 2012 and 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) for the period 2014 to 2019
  • Evaluate product life styles and technology life styles (TLC) of various types of sealants and methods employed by manufacturers and users in maintaining an ecological balance
  • Assess a breakdown of global and regional markets for sealants, with the purpose of locating newer markets and expanding the present market position for various types of sealants
SAMPLE FIGURE
GLOBAL MARKET FOR SEALANTS AND SEALANT APPLICATORS, 2012-2019
($ MILLIONS)

1382356227_chm074a-0

Click here to order your copy of this report (or any of its chapters) or to download the report overview chapter.


Follow

Get every new post delivered to your Inbox.

Join 29 other followers